Sign up today to learn more about Zymergen stock

EquityZen is a marketplace for shares of proven pre IPO tech companies

Zymergen Stock

Microbe research, development, and manufacturing



Notable Investors

Goldman Sachs


Emeryville CA, US

Total Funding


About Zymergen Stock

Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize strains that improve economics of in-market products, improve the existing production strains within existing manufacturing processes; and improve the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products.

Jed Dean, Joshua J. Hoffman, and Zachary Serber founded the company in 2013, with headquarters in Emeryville in California and an additional office in Seattle in Washington.


Funding History

June 2015$36.6M
June 2015$6.6M
October 2016$142M
November 2018$100.0M
November 2018$300M


Chief Executive Officer

Joshua Hoffman

Chief Science Officer

Zach Serber

VP of Operations and Engineering

Jed Dean

Chief Technical Officer

Aaron Kimball

Chief People Officer

Judy Gilbert

President, Products

Richard Pieters

VP of Finance

Enakshi Singh

Chief Marketing Officer

Jack Gold

Chief Legal Officer

Mina Kim


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Zymergen or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: